Speaker(s):
Lefulesele Kholoane, MD, Internal Medicine Resident, Staff Member, Geisinger - has nothing to disclose.
Moderator(s):
Connor Dougherty, DO, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Differentiate pathophysiologic differences in obstructive and central sleep apnea.
- Appraise current evidence for the role of phrenic nerve stimulation for treatment of CSA and hypoglossal nerve stimulation for treatment of OSA.
- Discuss strategies for better management of sleep apnea in the context of patient’s comorbidities.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Conner Dougherty, DO; Karlyn Paglia, MD; Juan R. Escobar, MD; Shashank Kotakonda, MD; Jayalakshmi Nair, MD; Jignesh Patel, MD; Jameson Woodard, MD; Hasan Zerti, MD and Eric Drago, MD have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA compliant.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation Credit